Aqr Capital Management LLC Cti Biopharma Corp Transaction History

Aqr Capital Management LLC

  • $71.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$4.2 - $6.01 $14,406 - $20,614
3,430 Added 9.49%
39,583 $166,000
Q4 2022

Feb 14, 2023
BUY
$4.45 - $6.17 $58,535 - $81,160
13,154 Added 57.19%
36,153 $217,000
Q3 2022

Nov 14, 2022
BUY
$5.36 - $7.43 $40,918 - $56,720
7,634 Added 49.68%
22,999 $134,000
Q1 2020

May 15, 2020
BUY
$0.69 - $1.54 $10,601 - $23,662
15,365 New
15,365 $14,000

About CTI BIOPHARMA CORP

CTIC Quotes by TradingView
  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email